The latest infant mortality data for England and Wales continue to show a stark difference between the most and least deprived areas and between ethnic groups. There were 2320 infant deaths (aged ...

The team responsible for managing the United States’ national guidance on safe and effective use of contraception has been dismissed, causing concern that an essential public health resource could be ...

The European Medicines Agency (EMA), after initial rejection based on an unfavourable risk-benefit balance, recently recommended approval of lecanemab for treating people with mild cognitive ...

A group of expert neurologists have expressed concerns at the European Commission’s (EC) decision to formally approve the Alzheimer’s drug lecanemab (Leqembi) despite uncertain benefits. Lecanemab, ...

Harvard University has defied demands from US president Donald Trump for control over academic decision making and instead sued his administration, charging it with violating the university’s ...

As the final draft of the 32 page pandemic accord1 lit up the giant screen at the World Health Organization’s (WHO) Geneva headquarters at 3 am on 16 April, the world’s health ministers and diplomats ...

The country’s success is a call to action for other affected areas China, burdened with an estimated 30 million malaria cases annually in the 1940s, reached a historic milestone when the World Health ...

Qiyong Liu and colleagues revisit the strategies and measures adopted in China to control and eliminate malaria and discuss what can be learnt from its elimination Malaria is a mosquito-borne ...

GP Bryony Kendall talks to Helen Jones about her role on NICE women’s and reproductive health guidelines committee “I always wanted to be a doctor, and it’s such a privilege and a joy to be a GP and ...

Huaiyu Tian and colleagues argue that to improve sustainable malaria control and reduce the risk of disease resurgence, targeted interventions can be optimised for eliminating malaria in areas ...

Improving people’s experiences during and between care episodes and reducing the fear and harm associated with long waits can restore public satisfaction in the NHS, writes Chris Graham Since the ...

Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...